Skip to main content
Clinical Trials/NL-OMON55962
NL-OMON55962
Recruiting
Not Applicable

Early detection of diastolic dysfunction and heart failure with preserved ejection fraction - EARLY-HFPEF

Vrije Universiteit Medisch Centrum0 sites900 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
900
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Males and females aged 50\-75 years;
  • duration of T2DM of at least 1 year (defined on the basis of previous diagnosis
  • and/or treatment with hypoglycaemic agents);
  • with informed consent to be contacted for future research;
  • able to provide a written consent form.

Exclusion Criteria

  • 1\. Advanced diabetes complications (like proliferative retinopathy, disabling
  • polyneuropathy, or stages IV\-V diabetic nephropathy). 2\. Cardiac comorbidity:
  • a) Valvular heart disease requiring surgery or intervention, or within 3 months
  • after valvular surgery or intervention. b) Hypertrophic obstructive
  • cardiomyopathy. c) Acute myocarditis, sarcoidosis, amyloidosis, Takotsubo
  • cardiomyopathy. d) Post\-heart transplant cardiomyopathy. e) Chronic HFrEF (a LV
  • EF of \< 50% assessed within 12 months prior to randomization). f) Clinical
  • diagnosis of HFpEF. g) Tachycardia\-induced cardiomyopathy and/or uncontrolled
  • tachyarrhythmia. h) Acute coronary syndrome (unstable angina, non\-ST elevation
  • myocardial infarction \[NSTEMI]or ST elevation myocardial infarction \[STEMI]) or

Outcomes

Primary Outcomes

Not specified

Similar Trials